Effects of a Rehabilitation Programme with a Nasal Inspiratory Restriction Device on Exercise Capacity and Quality of Life in COPD

Aurelio Arnedillo; Jose L Gonzalez-Montesinos; Jorge R Fernandez-Santos; Carmen Vaz-Pardal; Carolina España-Domínguez; Jesús G Ponce-González; Magdalena Cuenca-García

doi:10.3390/ijerph17103669

Effects of a Rehabilitation Programme with a Nasal Inspiratory Restriction Device on Exercise Capacity and Quality of Life in COPD

Int J Environ Res Public Health. 2020 May 22;17(10):3669. doi: 10.3390/ijerph17103669.

Authors

Aurelio Arnedillo¹, Jose L Gonzalez-Montesinos², Jorge R Fernandez-Santos^{2

3}, Carmen Vaz-Pardal⁴, Carolina España-Domínguez¹, Jesús G Ponce-González^{3

5}, Magdalena Cuenca-García^{2

3}

Affiliations

¹ Pneumology, Allergy and Thoracic Surgery Department, University Hospital Puerta del Mar, 11009 Cádiz, Spain.
² GALENO Research Group, Department of Physical Education, Faculty of Education Sciences, University of Cádiz, 11003 Puerto Real, Spain.
³ Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital University of Cádiz, 11009 Cádiz, Spain.
⁴ Bahía Sur Andalusian Center for Sports Medicine, 11100 Cádiz, Spain.
⁵ MOVE-IT Research Group, Department of Physical Education, Faculty of Education Sciences, University of Cádiz, 11003 Puerto Real, Spain.

Abstract

Objective: The objective was to assess the effects of a nasal restriction device for inspiratory muscle training, called Feelbreathe^®, added to a rehabilitation program (RP) on exercise capacity, quality of life, dyspnea and inspiratory muscle strength in patients with stable COPD.

Methods: Patients were randomized into three groups, one performed a supervised RP using the Feelbreathe^® device (FB group), the second group developed the same RP with oronasal breathing without FB (ONB group) and the third was the control group (CG). We evaluated inspiratory muscle strength (P_Imax), dyspnea (mMRC), quality of life (CAT) and exercise capacity (6MWT) before and after 8-week of RP.

Results: A total of 16 patients completed the study, seven in FB group, five in ONB group and four in the CG. After the RP, the FB group showed a significant increase in P_Imax (93.3 ± 19.1 vs. 123.0 ± 15.8 mmHg) and in the 6MWT distance (462.9 ± 71.8m vs. 529.1 ± 50.1 m) and a decrease in the CAT score (9.7 ± 6.5 vs. 5.9 ± 6.0) and in the mMRC dyspnea score. FB provides greater improvement in P_Imax, dyspnea, quality of life and 6MWT than ONB.

Conclusions: The Feelbreathe^® device provides greater improvements in quality of life, dyspnea, exercise capacity and inspiratory muscle strength compared to patients that did not use it.

Keywords: COPD; inspiratory muscle training; medical device; pulmonary rehabilitation.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Breathing Exercises / instrumentation*
Dyspnea
Exercise Tolerance*
Humans
Pulmonary Disease, Chronic Obstructive* / therapy
Quality of Life
Respiratory Muscles*